The impact of nanotechnology on myocardial infarction treatment.

173 ISSN 1743-5889 10.2217/NNM.11.184 Nanomedicine (2012) 7(2), 173–175 “Nanotechnology has the potential to play a role in improving outcomes from MI at multiple points in the disease process. These include earlier and more sensitive diagnosis of developing MI, improved treatments of acute MI with drugs, cell therapy and siRNA, and tissue engineering approaches for preventing infarct expansion and the development of heart failure.”